BMGL
Basel Medical Group Ltd
$8.35
▲ +22.79%$8.35▼ -60.24%
over 1Y
L $5.82H $43.44
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+22.8%
1W+24.4%
1M+26.9%
3M+16.9%
YTD+21.9%
1Y-60.2%
Sell
Conviction
Horizon
Medium (3–12mo)
Mixed signals in the latest filings.
Basel Medical Group Ltd shows limited reported revenue.
On these fundamentals, BMGL screens as SELL on the SEC figures.
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 10:04 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$13.1M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗6-KPeriod ending 2025-12-312026-06-26open ↗6-KPeriod ending 2026-06-102026-06-10open ↗6-KPeriod ending 2026-06-052026-06-05open ↗3Period ending 2026-03-182026-04-21open ↗3Period ending 2026-03-182026-04-15open ↗3Period ending 2026-03-182026-04-14open ↗3Period ending 2026-03-182026-04-14open ↗3Period ending 2026-03-182026-04-14open ↗3Period ending 2026-03-182026-04-14open ↗6-KPeriod ending 2026-03-302026-03-30open ↗6-KPeriod ending 2026-03-242026-03-24open ↗20-F/APeriod ending 2025-06-302026-03-13open ↗
Frequently asked
- Is Basel Medical Group Ltd (BMGL) a buy?
- BMGL currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
- What is Basel Medical Group Ltd's quality score?
- BMGL scores 47.50171998624009/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0002004489, latest 6-K filed 2026-06-26) · EODHD · as of 7/4/2026, 2:04:46 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.